Development and validation of a nomogram for predicting immunotherapy outcomes in lung cancer patients using clinical and blood biomarkers
The nomograms developed in this study, integrating clinical and blood biomarkers, provide a cost-effective, simple, and accurate tool for predicting the prognosis of lung cancer patients receiving ICIs treatment, to facilitate personalized clinical decision-making.
Authors
- Mi Yang (ORCID: https://orcid.org/0000-0001-6842-2769)
- Tianwei Luo
- Ning Han (ORCID: https://orcid.org/0009-0004-7847-6161)
- Xiaoyuan Chu (ORCID: https://orcid.org/0000-0003-0139-4526)
- Ting Ouyang
- Ao Chen (ORCID: https://orcid.org/0000-0002-5844-6748)
- Chao Chen (ORCID: https://orcid.org/0000-0002-4422-1716)
- Fei Zhang (ORCID: https://orcid.org/0000-0001-7434-7339)
- Jun Qian (ORCID: https://orcid.org/0000-0001-9585-9747)
- Yan Yang (ORCID: https://orcid.org/0000-0001-8492-6625)
Institutions
- Nanjing University of Chinese Medicine (CN)
- Nanjing General Hospital of Nanjing Military Command (CN)
- Nanjing Drum Tower Hospital (CN)
- Second Affiliated Hospital of Nanjing Medical University (CN)
- Nanjing Medical University (CN)
- Nanjing University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-08-22
- DOI
- https://doi.org/10.1186/s12885-025-14559-1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Nanjing University